Thomas Castles

New immigration policies are affecting the health of thousands of migrant children, and physicians want the world to know about it.

Misconceptions linger, and they’re not helping anyone.

Gun violence is an epidemic in the US, but research remains underfunded compared to other leading causes of mortality.

Those who tweet under the hashtag offer up free advice that can cost thousands of dollars elsewhere, either through CME credits or in medical school.

Following the novel gene-editing tech's approval for the treatment of cancer last year, researchers at Roski Eye Institute are exploring its potential to treat ophthalmic disease.

Nanophotoswitches have demonstrated promising results in rats. Will they one day improve transduction in damaged eyes, and restore lost vision in humans?

The burden of ophthalmic disease is rising. How can ophthalmologists rise to meet it?

75% of patients with newly-diagnosed, treatment naïve DME received no treatment within 1 year of diagnosis.

Researchers hypothesized that making eye care screens free also reduced perceived value of the services.

The majority of eyes treated in the DRCR Protocol S study had resolved, stable or improved NV at each follow-up visit.

The algorithm identified PPL-HMA in 20% of eyes and was associated with a 2-3 fold increased risk of DR progression, development of PDR and receipt of intravitreal injections over 4 years.

The deep learning algorithm was tested on 71,000 images, and offers the potential to significantly increase the speed at which DR can be identified.

Eyes that received only anti-VEGF experienced significantly worse visual acuity from initial visit to final visit.

Anti-VEGF and pan-retinal photocoagulation can be effective, but neither are "one-and-done" therapies. Physicians must be proactive about how they handle patients with PDR.

Remoxy ER is a thick, sticky, high-viscosity capsule formulation designed to deter abuse via injection, snorting and smoking.

Varicose veins were rarely thought to have severe health effects, but should now be monitored closely, new evidence suggests.

The medication has also been linked to increased risk of autism and reduced IQ.

The device's approval is the first of 2018 for Medtronic, who received agency clearance for 9 devices in last year.

Unapproved stem cell therapies now bring in $2.4 billion per year. The FDA is working to ensure they follow regulatory, safety and efficacy guidelines.

Interventions are lacking for MSDs, which can result in lost time at work and early retirement.

Spark Therapeutics CEO Jeff Marrazzo reassured patients and the medical community he has an obligation to ensure access to the novel gene therapy.

A new study suggests the novel therapy can help empower patients with psychoses.

Risks increase when a child’s mother, versus their father has a history of homelessness.

New evidence suggests HIV’s toll on the brain occurs very early in infection.

The approval marks the start of an agency effort to facilitate approvals of medication assisted treatment.

New evidence suggests the program has reversed a decades-long trend of reduced HF mortality.

87% of pediatric patients did not experience a bleeding episode that required treatment during phase 3 trials.

Fetuses of obese mothers have higher weight, larger head circumferences and some longer bones, according to a new study.

The therapy showed up to 51% reduction in the annual exacerbation rate versus placebo.

HIV patients are more likely to be depressed, which reduces treatment adherence. Here’s how dogs could help.